CN102552369B - 一种金银花叶提取物作为抗猪繁殖与呼吸综合征病毒剂的用途 - Google Patents
一种金银花叶提取物作为抗猪繁殖与呼吸综合征病毒剂的用途 Download PDFInfo
- Publication number
- CN102552369B CN102552369B CN201210032337.1A CN201210032337A CN102552369B CN 102552369 B CN102552369 B CN 102552369B CN 201210032337 A CN201210032337 A CN 201210032337A CN 102552369 B CN102552369 B CN 102552369B
- Authority
- CN
- China
- Prior art keywords
- flos lonicerae
- leaf
- ethanol water
- temperature
- prrsv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 title claims abstract description 19
- 244000167230 Lonicera japonica Species 0.000 title abstract description 6
- 235000017617 Lonicera japonica Nutrition 0.000 title abstract description 6
- 230000003612 virological effect Effects 0.000 title abstract description 4
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 claims abstract description 43
- 241000700605 Viruses Species 0.000 claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 230000002829 reductive effect Effects 0.000 claims abstract description 11
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 239000011347 resin Substances 0.000 claims abstract description 8
- 229920005989 resin Polymers 0.000 claims abstract description 8
- 241000628997 Flos Species 0.000 claims description 66
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 19
- 239000003456 ion exchange resin Substances 0.000 claims description 19
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 19
- 208000015181 infectious disease Diseases 0.000 claims description 17
- 238000010828 elution Methods 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 11
- 235000008504 concentrate Nutrition 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 230000001681 protective effect Effects 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 235000014666 liquid concentrate Nutrition 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 230000000274 adsorptive effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 238000001035 drying Methods 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 47
- 239000000243 solution Substances 0.000 description 19
- 239000003814 drug Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 8
- 230000010261 cell growth Effects 0.000 description 7
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 238000013467 fragmentation Methods 0.000 description 6
- 238000006062 fragmentation reaction Methods 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241001570521 Lonicera periclymenum Species 0.000 description 5
- 208000036142 Viral infection Diseases 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000005342 ion exchange Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000009385 viral infection Effects 0.000 description 5
- 239000003463 adsorbent Substances 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000013553 cell monolayer Substances 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 231100000668 minimum lethal dose Toxicity 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 241001292006 Arteriviridae Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 208000001572 Mycoplasma Pneumonia Diseases 0.000 description 1
- 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 1
- 101150082475 ORF7 gene Proteins 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- ZBHXIWJRIFEVQY-IHMPYVIRSA-N ceftiofur Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC(=O)C1=CC=CO1 ZBHXIWJRIFEVQY-IHMPYVIRSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229940024448 excenel Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940090044 injection Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 201000006509 pleuropneumonia Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210032337.1A CN102552369B (zh) | 2012-02-14 | 2012-02-14 | 一种金银花叶提取物作为抗猪繁殖与呼吸综合征病毒剂的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210032337.1A CN102552369B (zh) | 2012-02-14 | 2012-02-14 | 一种金银花叶提取物作为抗猪繁殖与呼吸综合征病毒剂的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552369A CN102552369A (zh) | 2012-07-11 |
CN102552369B true CN102552369B (zh) | 2014-01-15 |
Family
ID=46399826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210032337.1A Expired - Fee Related CN102552369B (zh) | 2012-02-14 | 2012-02-14 | 一种金银花叶提取物作为抗猪繁殖与呼吸综合征病毒剂的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552369B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103214371B (zh) * | 2013-04-17 | 2015-05-13 | 江西农业大学 | 二咖啡酰奎宁酸制备方法与应用 |
CN103830306B (zh) * | 2014-02-20 | 2017-08-25 | 鲁南制药集团股份有限公司 | 一种忍冬叶有效提取物的制备方法 |
CN113181232A (zh) * | 2021-05-27 | 2021-07-30 | 山东省科学院菏泽分院 | 一种治疗急性胰腺炎的物质 |
CN117016675A (zh) * | 2023-07-26 | 2023-11-10 | 四川农业大学 | 一种川银花叶提取物及其制备方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1616403A (zh) * | 2004-09-21 | 2005-05-18 | 济南永曜医药科技有限公司 | 从金银花中提取制备绿原酸的工艺 |
-
2012
- 2012-02-14 CN CN201210032337.1A patent/CN102552369B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102552369A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111888434B (zh) | 一种抗冠状病毒的中药颗粒剂及其制备方法和用途 | |
CN105198899B (zh) | 1‑烷基化瑞香烷型二萜及其在制备抗艾滋病毒药物中的用途 | |
CN102552369B (zh) | 一种金银花叶提取物作为抗猪繁殖与呼吸综合征病毒剂的用途 | |
CN101293012B (zh) | 一种抗病毒金银花中药复方制剂及制备工艺 | |
CN115105502B (zh) | 一种含千金藤属植物生物碱的化合物在制备猫传染性腹膜炎药物中的应用 | |
WO2010040254A1 (zh) | 黄芩黄酮在制备治疗肠道病毒感染药物的应用 | |
CN102319287B (zh) | 一种薄荷酚酸提取物及其在制备抗呼吸道合胞病毒药物中的应用 | |
CN102716245A (zh) | 中药组合物在制备抗71型肠道病毒的药物中的用途 | |
CN103356728B (zh) | 一种药物组合物及其制备方法、制剂与应用 | |
CN102198192B (zh) | 一种防治甲流的中药组合物及其应用 | |
CN109432392A (zh) | 一种治疗非洲猪瘟的肽制剂及其制备方法 | |
CN106237050A (zh) | 一种有效防治h1n1和h3n2猪流感以及猪蓝耳病的中药复方及其制备方法 | |
CN105943820A (zh) | 一种抗猪流感以及蓝耳病的中药复方及提取方法 | |
CN105106254A (zh) | 一种抗流感病毒的珍珠菜提取物 | |
CN100506273C (zh) | 浓缩型抗病毒口服液的制备方法 | |
CN104147062A (zh) | 一种畜禽使用的酶提取中药颗粒的制备方法 | |
CN103816258B (zh) | 一种用于治疗前列腺癌的中药组合物及其制备方法和应用 | |
CN104161902B (zh) | 一种药物组合物及其制剂在制备抗流感药物中的新用途 | |
CN116850231B (zh) | 一种用百合炮制生地黄的方法 | |
CN106377714A (zh) | 祖卡木颗粒在制备治疗病毒性流感药物中的应用 | |
CN106421329A (zh) | 一种同时抗猪流感以及蓝耳病的中药复方及提取方法 | |
CN106974985A (zh) | 一种茶皂素有效部位的制备及其抗家畜病毒的新用途 | |
CN105031103A (zh) | 一种用于治疗尿路感染的药物制剂 | |
CN113244276A (zh) | 桑黄或桑黄提取物作为新型冠状病毒治疗药物或抗病毒制剂的用途 | |
CN113230288A (zh) | 百蕊草或百蕊草提取物或百蕊草萃取物作为新型冠状病毒治疗药物或抗病毒制剂用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SANXIA UNIVERSITY Free format text: FORMER OWNER: CHEN JIANFENG Effective date: 20141231 Free format text: FORMER OWNER: ZOU KUN Effective date: 20141231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20141231 Address after: 443002 Yichang University Road, Hubei, No. 8 Patentee after: CHINA THREE GORGES University Address before: 443002 School of life science, China Three Gorges University, Hubei, Yichang Patentee before: Chen Jianfeng Patentee before: Zou Kun |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140115 |
|
CF01 | Termination of patent right due to non-payment of annual fee |